Artiva Biotherapeutics In...

NASDAQ: ARTV · Real-Time Price · USD
2.77
0.07 (2.59%)
At close: Aug 15, 2025, 3:59 PM
2.75
-0.54%
After-hours: Aug 15, 2025, 04:10 PM EDT

Artiva Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-65.37M -28.72M -58.79M -71.83M
Depreciation & Amortization
2.43M 2.27M 1.16M 248K
Stock-Based Compensation
6.98M 7.05M 6.58M 4.31M
Other Working Capital
-2.46M -27.36M -2.38M 28.92M
Other Non-Cash Items
1.25M 251K n/a 18.55M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-325K -28.28M -3.87M 33.41M
Operating Cash Flow
-55.03M -47.43M -50.83M -15.3M
Capital Expenditures
-642K -3.26M -6.3M -1.72M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-176.17M -49.52M n/a n/a
Sales Maturities Of Investments
56.35M 26.8M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-120.46M -25.98M -6.3M -1.72M
Debt Repayment
-149K n/a n/a n/a
Common Stock Repurchased
-4.18M -12K -5K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
51K 24.4M -1.26M -1.86M
Financial Cash Flow
162.23M 24.39M -1.26M 152.75M
Net Cash Flow
-13.27M -49.01M -58.39M 135.73M
Free Cash Flow
-55.67M -50.69M -57.13M -17.03M